We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb: FDA to Expand Non-Prescription Access to Drugs in 2018
Gottlieb: FDA to Expand Non-Prescription Access to Drugs in 2018
In the coming year, the FDA’s top priorities will include broadening non-prescription access to drugs and updating compounder regulations, according to Commissioner Scott Gottlieb.